Lead a global organization of 50+ engineers and managers responsible for R&D of robotic catheters, bronchoscopes, vision probes, flexible biopsy needles, and therapeutic devices for the Ion endoluminal platform. Scaled product portfolios to support ~150,000 annual procedures worldwide. Accountable for platform architecture evolution, system-level integration with robotics hardware, software, and sensing technologies, and governance of a $50M+ annual R&D budget. Drive margin expansion, reliability, and next-generation technology strategy across a rapidly growing clinical footprint.

Impact Highlights

• Scaled commercial platform to global procedural volume leadership
• Delivered next-generation robotic catheter architectures
• Drove robustness, manufacturability, and cost structure improvements

Led matrixed, cross-functional governance across product, quality, supply chain, and clinical teams

Led integration of Vytronus technology and teams following acquisition. Directed early-stage platform architecture strategy for next-generation robotic endoluminal surgical systems, including voice-of-customer–driven concept development and proof-of-concept prototypes. Served as technical advisor on complex catheter design for manufacturability challenges.

Executive leader for R&D, Quality, and Manufacturing for robotics-enabled cardiac ablation platforms. Owned end-to-end product development, system-level risk governance, and clinical readiness for complex therapeutic devices. Built and scaled a 40-person organization and managed a $14M annual budget.

Impact Highlights

• Led development of robotic ultrasound imaging and ablation systems for atrial fibrillation
• Established and governed ISO 13485:2016 quality system
• Directed clinical trial execution from device readiness through physician training and case support
• Built and led company IP strategy, resulting in 23 granted U.S. patents
• Drove FDA engagement strategy, including BDD and pre-IDE interactions

Led technical integration of Hansen Medical technologies into the Auris platform, directly contributing to the strategic positioning and successful acquisition by Johnson & Johnson.

Executive owner of company-wide product development and technology strategy. Led multi-disciplinary engineering organizations and represented technology platforms to acquirers, investors, and Board stakeholders.

Impact Highlights

• Drove successful sale of Hansen Medical to Auris Health
• Led global R&D organization of 48 engineers across hardware, software, and systems
• Restructured and defended design control and risk management systems during FDA and Notified Body audits

Owned next-generation product roadmaps and platform strategy for robotic systems and steerable catheters. Served as executive liaison to key opinion leaders across vascular surgery, interventional radiology, and cardiology.

Impact Highlights

• Built long-range technology strategy for robotic catheter platforms
• Drove strategic partnerships across imaging and therapeutic technology companies
• Led IP portfolio strategy resulting in 150+ granted patents

Led development and global launch of a robotically controlled, 10-degree-of-freedom vascular catheter system from concept through commercialization. Managed teams of 18+ senior engineers and controlled $15M+ budgets.

Directed multiple advanced product development teams delivering next-generation robotic steerable catheter systems using DFSS methodologies. Launched the company’s first robotically controlled irrigated RF ablation catheter.

Built high-performance engineering teams and improved manufacturing yields from 50% to 90% while increasing throughput by 200%. Led successful international manufacturing transfer, completed under budget.

Selected to lead a corporate internal venture to design and launch the first disposable colonoscope. Led development from concept through first-in-human clinical use.

Highlights

• Built and led multi-disciplinary engineering teams
• Delivered first clinical use of disposable endoscopy platform
• Established advanced mechanical and system test infrastructures

Technical lead for Express LD stent system, coordinating development across global sites and leading teams through successful U.S. and European product launches.

Early-career engineering leadership in development of renal, biliary, coronary, and gastrointestinal stent systems, including verification testing, manufacturing process development, and regulatory submissions.